ABSTRACT
Adiponectin is an adipose tissue derived mediator with significant anti atherosclerotic properties and is involved in the regulation of insulin sensitivity and lipid oxidation, a few studies were done in acute phase of myocardial infarction, especially in none obese patients. The study investigated the association between adiponectin concentration and acute phase of myocardial infarction [MI] in non obese men patients. The results showed that adiponectin levels in patients with AMI [5.2ug/ml] were significantly lower than that of control group [7.5ug/ml] [P<0.001]. Lower adiponectin levels were independently associated with higher risk of AMI [odd ratio= 6.12, 95% CIs: 2.4-18.6; P=<0.001]. Adiponectin levels were negatively correlated with triglyceride [r=-0.34] in case group and [r=-0.41] in control group [P< 0.001]. In addition, negatively correlated with BMI [r=-0.27] in case group and [r=-0.23] in control group [P< 0.001], but adiponectin levels is positively correlated with HDL-Cholesterol [r= 0.45] in case group and [r=0.51] in control group with [P<0.001]